NDC - HCPCS Crosswalk

Effective January 1, 2019 through March 31, 2019

The crosswalk is intended to help understand which drug products -identified by NDCs- are assigned to which HCPCS billing codes. The crosswalk is not intended to be a comprehensive list of all NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units.

NDC HCPCS Code Labeler Drug Name Dosage Package Size Package Quantity Billable Units Billable Units / Pkg
10019-926-02J9208Baxter Healthcare CorporationIfosfamide injection1 GM1133
63323-142-10J9208Fresenius Kabi USA LLCIfosfamide injection1 GM1111
63323-142-12J9208Fresenius Kabi USA LLCIfosfamide injection1 GM1111
0338-1305-01J9209Baxter Healthcare CorporationMesna injection200 MG10155
0338-1305-03J9209Baxter Healthcare CorporationMesna injection200 MG1010550
0703-4805-01J9209Sicor Pharmaceuticals, Inc.Mesna injection200 MG10155
10019-953-01J9209Baxter Healthcare CorporationMesna injection200 MG10155
10019-953-02J9209Baxter Healthcare CorporationMesna injection200 MG1010550
25021-201-10J9209Sagent Pharmaceuticals IncMesna injection200 MG10155
25021-201-11J9209Sagent Pharmaceuticals IncMesna injection200 MG1010550
25021-201-68J9209Sagent Pharmaceuticals IncMesna injection200 MG10155
25021-201-69J9209Sagent Pharmaceuticals IncMesna injection200 MG1010550
47781-622-22J9209ALVOGENMesna injection200 MG10155
47781-622-91J9209ALVOGENMesna injection200 MG1010550
63323-733-10J9209Fresenius Kabi USA LLCMesna injection200 MG1010550
63323-733-11J9209Fresenius Kabi USA LLCMesna injection200 MG10155
70860-209-10J9209ATHENEX PHARMACEUTICALMesna injection200 MG10155
0013-2576-91J9211Pfizer Inc.Idarubicin hcl injection5 MG5111
0013-2586-91J9211Pfizer Inc.Idarubicin hcl injection5 MG10122
0013-2596-91J9211Pfizer Inc.Idarubicin hcl injection5 MG20144
0143-9217-01J9211West-Ward Pharmaceuticals CorpIdarubicin hcl injection5 MG5111
0143-9218-01J9211West-Ward Pharmaceuticals CorpIdarubicin hcl injection5 MG10122
0143-9219-01J9211West-Ward Pharmaceuticals CorpIdarubicin hcl injection5 MG20144
0143-9306-01J9211WEST-WARD PHARMACEUTICAL CORP.Idarubicin hcl injection5 MG5111
0143-9307-01J9211WEST-WARD PHARMACEUTICAL CORP.Idarubicin hcl injection5 MG10122
0143-9308-01J9211WEST-WARD PHARMACEUTICAL CORP.Idarubicin hcl injection5 MG20144
0703-4154-11J9211Sicor Pharmaceuticals, Inc.Idarubicin hcl injection5 MG5111
0703-4155-11J9211Sicor Pharmaceuticals, Inc.Idarubicin hcl injection5 MG10122
0703-4156-11J9211Sicor Pharmaceuticals, Inc.Idarubicin hcl injection5 MG20144
63323-194-20J9211Fresenius Kabi USA LLCIdarubicin hcl injection5 MG20144
0085-1133-01J9214Schering CorporationInterferon alfa-2b inj1 MIL UNITS2.512525
0085-1168-01J9214Schering CorporationInterferon alfa-2b inj1 MIL UNITS311818
0085-4350-01J9214Schering CorporationInterferon alfa-2b inj1 MIL UNITS111010
0085-4351-01J9214Schering CorporationInterferon alfa-2b inj1 MIL UNITS111818
0085-4352-01J9214Schering CorporationInterferon alfa-2b inj1 MIL UNITS115050
0074-2108-03J9217AbbVie US, LLCLeuprolide acetate suspnsion7.5 MG1111
0074-2440-03J9217AbbVie US, LLCLeuprolide acetate suspnsion7.5 MG1122
0074-3346-03J9217AbbVie US, LLCLeuprolide acetate suspnsion7.5 MG1133
0074-3473-03J9217AbbVie US, LLCLeuprolide acetate suspnsion7.5 MG1166
0074-3642-03J9217AbbVie US, LLCLeuprolide acetate suspnsion7.5 MG1111
0074-3683-03J9217AbbVie US, LLCLeuprolide acetate suspnsion7.5 MG1144
62935-222-05J9217TolmarLeuprolide acetate suspnsion7.5 MG1133
62935-223-05J9217TolmarLeuprolide acetate suspnsion7.5 MG1133
62935-302-30J9217TolmarLeuprolide acetate suspnsion7.5 MG1144
62935-303-30J9217TolmarLeuprolide acetate suspnsion7.5 MG1144
62935-452-45J9217TolmarLeuprolide acetate suspnsion7.5 MG1166
62935-453-45J9217TolmarLeuprolide acetate suspnsion7.5 MG1166
62935-752-75J9217TolmarLeuprolide acetate suspnsion7.5 MG1111
62935-753-75J9217TolmarLeuprolide acetate suspnsion7.5 MG1111
0781-4003-32J9218Sandoz, Inc.Leuprolide acetate injeciton1 MG2.811414
47335-936-40J9218Sun Pharmaceutical Global Fze.Leuprolide acetate injeciton1 MG2.811414
67979-500-01J9225Endo Pharmaceuticals Valera Inc.Vantas implant50 MG1111
67979-002-01J9226Endo Pharmaceuticals Valera Inc.Supprelin la implant50 MG1111
0003-2327-11J9228Bristol-Myers Squibb CompanyIpilimumab injection1 MG1015050
0003-2328-22J9228Bristol-Myers Squibb CompanyIpilimumab injection1 MG401200200
55292-911-51J9230Recordati Rare DiseasesMechlorethamine hcl inj10 MG1414
25021-221-60J9245Sagent Pharmaceuticals IncInj melphalan hydrochl 50 mg50 MG1111
42023-149-01J9245Par Pharmaceutical, IncInj melphalan hydrochl 50 mg50 MG1111
43598-392-48J9245Dr. Reddy's Laboratories, Inc.Inj melphalan hydrochl 50 mg50 MG1111
45963-686-02J9245Actavis Pharma, Inc.Inj melphalan hydrochl 50 mg50 MG1111
Page 60